| Date Filed | Type | Description |
| 11/21/2022 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Acrivon Therapeutics, Inc.|
Txns:
| Converted 888,130 shares
@ $0
Converted 2,190,131 preferred shares
@ $0 |
|
| 11/09/2022 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Acrivon Therapeutics, Inc. |
| 02/04/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/04/2022 |
SC 13G/A
| Wellington Biomedical Innovation Master Investors I L.P. reports a 2.8% stake in Aligos Therapeutics, Inc. |
| 08/03/2021 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Nuvalent, Inc.|
Txns:
| Converted 897,671 shares
@ $0
Converted 4,831,384 preferred shares
@ $0 |
|
| 07/28/2021 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Nuvalent, Inc. |
| 06/28/2021 |
SC 13G
| Wellington Biomedical Innovation Master Investors I L.P. reports a 5.2% stake in Verve Therapeutics, Inc. |
| 06/22/2021 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Verve Therapeutics, Inc.|
Txns:
| Converted 1,343,081 shares
@ $0
Converted 1,152,490 shares
@ $0
Converted 12,436,264 preferred shares
@ $0
Converted 10,671,482 preferred shares
@ $0 |
|
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/30/2021 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Converted 681,812 shares
@ $0
Converted 681,812 preferred shares
@ $0 |
|
| 03/25/2021 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Edgewise Therapeutics, Inc. |
| 11/24/2020 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Olema Pharmaceuticals, Inc.|
Txns:
| Converted 1,273,420 shares
@ $0
Converted 451,986 shares
@ $0
Converted 1,273,420 preferred shares
@ $0
Converted 451,986 preferred shares
@ $0 |
|
| 11/18/2020 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Olema Pharmaceuticals, Inc. |
| 10/22/2020 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Aligos Therapeutics, Inc.|
Txns:
| Converted 1,335,048 shares
@ $0
Converted 571,143 shares
@ $0
Converted 1,335,048 convertible preferred
@ $0
Converted 571,143 convertible preferred
@ $0 |
|
| 10/22/2020 |
SC 13G
| Wellington Biomedical Innovation Master Investors I L.P. reports a 5.3% stake in Aligos Therapeutics, Inc. |
| 10/15/2020 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Aligos Therapeutics, Inc. |
| 09/29/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (Former 10% Owner) has filed a Form 3 on PMV Pharmaceuticals, Inc. |
| 09/23/2020 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Dyne Therapeutics, Inc.|
Txns:
| Converted 1,608,785 shares
@ $0
Converted 5,336,179 preferred shares
@ $0 |
|
| 09/16/2020 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Dyne Therapeutics, Inc. |
| 09/03/2020 |
D/A
| Form D/A - Notice of Exempt Offering of Securities: [Amend] |
| 08/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/20/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 07/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/23/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Forma Therapeutics Holdings, Inc., |
| 06/18/2020 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Generation Bio Co.|
Txns:
| Converted 1,012,546 shares
@ $0
Bought 1,100,000 shares
@ $19, valued at
$20.9M
Converted 1,788,460 preferred shares
@ $0 |
|
| 06/11/2020 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Generation Bio Co. |
| 02/05/2020 |
4
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 4 on Black Diamond Therapeutics, Inc.|
Txns:
| Converted 568,185 shares
@ $0
Converted 1,713,541 preferred shares
@ $0 |
|
| 01/29/2020 |
3
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. (10% Owner) has filed a Form 3 on Black Diamond Therapeutics, Inc. |
| 10/03/2019 |
D
| Form D - Notice of Exempt Offering of Securities: |